Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis - Test2 - elhamkhani - TriplyDB

Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis

Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis

http://www.wikidata.org/entity/Q26825582

about

Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis Selected aspects of the current management of myositis Autoimmune Myopathies: Where Do We Stand?Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.Cutaneous dermatomyositis: an updated review of treatment options and internal associations.Meta-analysis of the association of dermatomyositis and polymyositis with cancer.Review: cancer-induced autoimmunity in the rheumatic diseases.Cancer risk in dermatomyositis: a meta-analysis of cohort studies.Expression of the dermatomyositis autoantigen transcription intermediary factor 1γ in regenerating muscle.Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis.Investigation of publication bias in meta-analyses of diagnostic test accuracy: a meta-epidemiological study Myositis autoantibodies and clinical phenotypes.Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies.Autoantibodies to transcription intermediary factor TIF1β associated with dermatomyositis.PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome.Polymyositis and dermatomyositis as a risk of developing cancer.Clinical characteristics of patients with anti-TIF1-γ antibodies Latest advances in connective tissue disorders.Anti-transcription intermediary factor 1-gamma autoantibody ELISA development and validation Paraneoplastic syndrome in Hawai'i: a case of dermatomyositis associated with endometrial cancer Myositis autoantibodies.Autoantibodies in polymyositis and dermatomyositis.The evolving spectrum of polymyositis and dermatomyositis--moving towards clinicoserological syndromes: a critical review.Malignancy and idiopathic inflammatory myopathies Paraneoplastic syndromes in rheumatology.Regional ischemic immune myopathy: a paraneoplastic dermatomyopathy.Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies.Inflammatory myopathy: diagnosis and clinical course, specific clinical scenarios and new complementary tools.A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.The Clinical Features of Myositis-Associated Autoantibodies: a Review.Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.Malignancy screening in autoimmune myositis amongst Australian Rheumatologists.Expression of the autoantigen TRIM33/TIF1γ in skin and muscle of patients with dermatomyositis is upregulated, together with markers of cellular stress.Sporadic inclusion body myositis - a myodegenerative disease or an inflammatory myopathy.Anti-MDA5-Positive Dermatomyositis Presenting as Fever of Unknown Origin.

P2860

Q21090635-14484DEF-C5FA-4CED-AF59-357DEEA08F87 Q26738952-5698593F-6DC3-481B-B055-72E8C3256185 Q26744554-B4BAF7EA-821E-4092-B635-F63E63BD8B11 Q26863125-0C2AD527-D9D1-4168-93BA-2134D5C79512 Q30252086-9428F6B1-80DD-42A8-937A-A34548E9D197 Q33688739-727702F6-F586-4EFA-93B6-4A6EFF6EA226 Q33714734-330B33D9-729E-4687-B9C8-28A7CCD46A2E Q33814323-EBBDE3F5-AD27-4792-BB2C-7990E90D207E Q34349952-76FF4A79-65FA-4504-BBE0-4F5F39548470 Q34654935-96DA56DA-D491-40B7-8916-EC78D6BC251F Q34666066-63951957-924E-46EB-BF88-65CA79497341 Q34668158-C83EA1DC-8C38-4D07-AE56-73FDD1122EBB Q34791339-A52BADBD-C894-4A75-8869-BEB8DB05932B Q35153899-44242E90-3E06-4B59-A578-7A082805B132 Q35177554-C313D85E-78F3-4BCA-9BB5-5D537191A55D Q35281962-BB64DC29-9A52-41CE-AE03-F258D259B9E5 Q36014488-EFDC1FE7-FFF7-481C-89D1-88436EE6E512 Q36245820-BC1F3661-A88E-469C-8572-6DCDE2C8A46C Q36788809-A3284EBB-83BC-48A3-8450-701822660EB2 Q36842357-288EC8A7-873D-43C7-B483-FACA65137DFB Q36842501-9AE7518B-40DC-4697-83C0-533BBBB79C6D Q37058776-C9D48AF3-42CD-46B5-97F7-3931E47A6FF3 Q37595996-2D98B210-D0E2-4D73-A46B-62458A5DFBEA Q37720854-A655E99B-A5C9-4BE7-8595-1CFADAABE11C Q38041385-89DC55FB-CB26-495F-9071-F446DFCF862B Q38099556-29309432-C11B-4118-B042-2F8D21F401D5 Q38139286-96E85E28-D96A-406F-84CC-3B8D34D27640 Q38172212-59A0DC15-CB13-4EA4-BD5F-25F931960AB9 Q38241229-E9F02761-B38F-4AD2-937E-E01245CE0432 Q38266506-59BC03D7-D891-40F5-A2B3-068CE3EB722F Q38281749-199E6BAD-3164-48FC-A75C-49CE35E94BBE Q38450473-B2F871FE-9042-42E7-990F-6A1E26B9BCC2 Q38596370-B614FB84-89C7-4571-A60B-C31D3F612147 Q38597575-207FAD20-3147-4300-B149-6F2E40A7A016 Q38603422-D44FB9B5-F8B1-4EB7-AC37-534AE8466A04 Q38646384-24DBC5CE-B7FC-434B-BD82-454E211B3E2D Q38662460-30701BA1-BF42-434F-9721-6D04C5F7211F Q38714316-C9AADFDC-2B35-4ADF-BBFA-34C6243DA616 Q38767200-D8A4C737-A191-4C56-9D22-89553705EEE9 Q38879035-034C236E-3809-4DD0-B43D-F0F7559884D6

P2860

Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis

http://www.wikidata.org/entity/Q26825582

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Usefulness of anti-p155 autoan ...... matic review and meta-analysis

@ast

Usefulness of anti-p155 autoan ...... matic review and meta-analysis

@en

Usefulness of anti-p155 autoan ...... matic review and meta-analysis

@nl

type

label

Usefulness of anti-p155 autoan ...... matic review and meta-analysis

@ast

Usefulness of anti-p155 autoan ...... matic review and meta-analysis

@en

Usefulness of anti-p155 autoan ...... matic review and meta-analysis

@nl

prefLabel

Usefulness of anti-p155 autoan ...... matic review and meta-analysis

@ast

Usefulness of anti-p155 autoan ...... matic review and meta-analysis

@en

Usefulness of anti-p155 autoan ...... matic review and meta-analysis

@nl

P1433

Q26825582-3F6D5726-2725-436C-BBFD-4B6C915DC963

P1476

Q26825582-F5690EA6-0B68-4AAC-BF63-5615C2C1F629

P2093

Q26825582-210B5C62-48C2-4F45-AA48-29B527725438

Q26825582-59283E92-70F0-44D4-80C1-8C82565AE311

Q26825582-62DC5661-FAA7-4AFD-A9A4-4E9E65C66BFC

Q26825582-89D6E24B-4B75-4573-AFAB-BE2681BA401E

Q26825582-FF1F2EC5-7F03-4680-A833-29E8A452355C

P2860

Q26825582-0040578E-C3DF-4ACB-9274-13326431BD11

Q26825582-009DC72D-DA76-4301-B131-BBA1FDBE96B3

Q26825582-041FE647-510E-4BF9-B51A-E26C8E704BAF

Q26825582-112FF941-C28C-4BD7-8734-0EAFF17FEC56

Q26825582-2DADEC4D-3758-4CA3-A90A-51D5E8EAE4AE

Q26825582-34C2089C-AA6F-49E6-8756-5010EF5AB895

Q26825582-47F84179-7797-4CB1-854D-E8E30DFCF97F

Q26825582-48A4A2DA-E522-482B-9EBF-FF3C650C2880

Q26825582-53091705-62FF-499D-9F9F-30EE77916D82

Q26825582-558841CD-933A-4B19-A9EA-0AE1EE48BAC6

P304

Q26825582-9143BE03-AC14-4621-AB46-DDFA771F9AE8

P31

Q26825582-3E0DBEDC-AF81-4BF3-965C-797C818A14A4

Q26825582-80C25EF5-9117-4E15-A2D5-D1D32BBEF1BB

Q26825582-F3003E83-89BC-41B1-B6B7-A51B64B3E7FE

P3181

Q26825582-67CF580A-08FA-4DC7-94D8-0A1AD34A6858

P356

Q26825582-051F0749-3E1F-4A91-B3D1-3FDA894F9E6F

P407

Q26825582-ECA5DB8F-117B-4112-9528-1F285DD8EA94

P433

Q26825582-03711652-CB80-4FD2-B700-F19928C4B4B4

P478

Q26825582-8EA4FDF7-0895-4B3D-9759-D1B7C4E1C20C

P50

Q26825582-18C19BFD-9642-4D8B-B497-4675DAFDD006

Q26825582-749CB04E-AB8C-4F90-9AE6-CFB23FA473A5

Q26825582-C7AE31C9-1E17-47E7-8FF7-4BDD7D6851EE

P577

Q26825582-2BAB609F-1C62-4FDC-9031-50DD0D187B22

P5875

Q26825582-D51473B4-B9F4-410C-B813-80B4831FEC80

P698

Q26825582-F4947229-4901-4ADB-B61E-6E957D9059B2

P921

Q26825582-1E5D524D-D825-4400-8C69-BE2CFF58A459

Q26825582-6E4A144C-E6B9-41FA-A2DC-DD79EFA1A345

Q26825582-9953078C-748B-4228-BF51-AB64963D2F02

P3181

P356

P1433

Arthritis and Rheumatism

P1476

Usefulness of anti-p155 autoan ...... matic review and meta-analysis

@en

P2093

Albert Selva-O'Callaghan

http://www.w3.org/2001/XMLSchema#string

Josep Maria Grau-Junyent

http://www.w3.org/2001/XMLSchema#string

Miquel Vilardell-Tarrés

http://www.w3.org/2001/XMLSchema#string

Xavier Bosch

http://www.w3.org/2001/XMLSchema#string

Xavier Martínez-Gómez

http://www.w3.org/2001/XMLSchema#string

P2860

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

Measuring inconsistency in meta-analyses

Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study

Measuring the accuracy of diagnostic systems

Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews

Myositis overlap syndromes.

Polymyositis and dermatomyositis (second of two parts).

Polymyositis and dermatomyositis (first of two parts).

Screening for tumours in paraneoplastic syndromes: report of an EFNS task force.

The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis

P304

523-532

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

804099

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/ART.33379

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

Moises Labrador-Horrillo

José Ángel Rodrigo Pendás

Ernesto Trallero-Araguás

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51668257

http://www.w3.org/2001/XMLSchema#string

P698

21953614

http://www.w3.org/2001/XMLSchema#string

P921

dermatomyositis